SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-28
👔
Scribe Therapeutics, Inc.
@SCTX_InsiderForm 4 Filing: Staahl Brett Acquires (Grant) shares of $SCTX
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
Scribe Therapeutics, Inc.
Ticker: $SCTX
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-03-13
Shares: 43,525
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Staahl Brett, holds the title of 10% Owner at Scribe Therapeutics, Inc..
On 2026-03-13, the insider transacted 43,525 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Staahl Brett (10% Owner) was granted $0 of $SCTX
Post-Transaction Position: 4,755 shares
SEC Accession No: 0002147277-26-000003 (CIK: 2147277)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.